NCT06287255Active, not recruiting
Feasibility and Acceptability of Incorporating Smartwatches Into an Exercise is Medicine Program in Older Individuals
Feasibility and Acceptability of Incorporating Fitbit Smartwatches Into a Health System Referral Based Exercise is Medicine Program in Older Individuals (EIM+)
Source: ClinicalTrials.gov · Last updated 5 Dec 2025
Brief summary (registry, in English)
The effects of exercise on prevention and improved control of chronic diseases, reduced mortality, and improved quality of life are well established. Exercise has been shown to prevent heart disease, stroke, type 2 diabetes, depression, and certain types of cancers. In addition to prevention, physical activity is included in the standard or care for many chronic diseases and used in treatment. For example, the American Diabetes Association has identified positive health behaviors like physical activity as foundational in the treatment and management of disease and improving overall quality of life. The Ohio State University Wexner Medical Center Exercise is Medicine Program (EIM) is a physician referral program that aims to increase physical activity to prevent and reduce complications from chronic disease. The integration of technology among a 65+ population of EIM participants provides a novel approach to improving individual's health. Thus, our study aims to provide EIM participants aged 65+ with smartwatches in the hopes of increasing their overall physical activity levels.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 150 (estimated)
- First submitted
- 5 Feb 2024
- Start date
- 15 Mar 2024
- Primary completion date
- 1 May 2026
- Lead sponsor
- Ohio State University
- Diseases
- Obesity
- NCT number
- NCT06287255
What you commit to
- Study type: Interventional
- Planned participants: 150
- From 15 Mar 2024 to the primary completion date, 1 May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Major surgery within the past three months
Other illness
- Symptoms suggestive of coronary artery disease (CAD) or congestive heart failure (CHF) (i.e. chest pain, dizziness, syncope, excessive dyspnea on exertion)
- Myocardial infarction within the last 12 months
- Stroke/transient ischemic attack (TIA) within the past 12 months
- Unstable angina
- Congestive heart failure (New York Heart Association (NYHA) Class II, III or IV)
- Ventricular arrhythmia
- Clinically significant cardiac valve disease
- Uncontrolled seizure disorder
Lab values
- Inability to independently manage blood glucose during activity
Other
- Revascularization within the last 12 months
- Blood pressure \>160/100 mmHg
- Severe or frequent hypoglycemia
- Severe autonomic or peripheral neuropathy
- Active foot ulcers
- Unstable retinopathy.
Who the study is looking for
- Age 65+
- No healthcare provider-imposed limitations on physical activity
- English-speaking
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Ohio State University Coordinator of this site? Confirm its status | Columbus | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.